At a Glance
Dosage
Only in ALD-52
oral
| Level | Dose |
|---|---|
| Threshold | 30 µg |
| Light | 30–100 µg |
| Common | 100–175 µg |
| Strong | 175–325 µg |
| Heavy | 325 µg |
Only in 25B-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong |
Duration
Only in ALD-52
oral
Total: 8 hrs – 14 hrsPeak
Offset
Afterglow
Onset20 min – 40 min
Come Up1 hrs – 2 hrs
Peak3 hrs – 5 hrs
Offset3 hrs – 5 hrs
Effects
Safety
Interaction: ALD-52 + 25B-NBOMe
No direct interaction data available between these substances. This does not mean the combination is safe.
ALD-52 — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between ALD-52 and 25B-NBOMe?
ALD-52 is classified as a Psychedelic (Lysergamides) while 25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 33 effects in common, with 38 effects unique to ALD-52 and 9 unique to 25B-NBOMe.
Is it safe to combine ALD-52 and 25B-NBOMe?
There is no direct interaction data available for combining ALD-52 and 25B-NBOMe. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, ALD-52 or 25B-NBOMe?
ALD-52 and 25B-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.